News Feed
XORTX Files U.S. FDA Pre-IND Meeting Request for XRx-101 (Oxypurinol) COVID-19 Program and Pre-IND Meeting Submission
● Potential of Acute Kidney Injury Emerging as a Serious Consequence of COVID-19 ● […]
Month: August 2020
News Feed
Citius Pharmaceuticals Announces Improved Design and Expansion of Intellectual Property for Mino-Wrap
Expansion of patents granted to The University of Texas System on behalf of M. D. Anderson Cancer Center […]
Featured Interviews
Xortx Therapeutics (CSE: XRX) (OTCQB: XRTXF)
Xortx CEO Dr. Allen Davidoff took time to update investors on the company’s accomplishments over the last several months. XRX just announced a partnership with Mount Sinai’s Icahn school of medicine for a US based COVID-19 clinical trial for acute kidney injury associated with the virus. […]
News Feed
XORTX Appoints Dr. David Sans in New York as Director Corporate Development
Dr. David Sans stated, “With forty million Americans living with kidney diseases and 700,000 having kidney failure, millions of lives are impacted by kidney-related illnesses. […]
News Feed
XORTX Partners with Mount Sinai’s Icahn School of Medicine on US-based Clinical Trial in COVID-19
● Exploring Elevated Uric Acid in Acute Kidney Injury from COVID-19 ● […]